Price target
3.980.000.00%
The 6 analysts offering 1 year price forecasts for ITH have a max estimate of — and a min estimate of —.
Analyst rating
Based on 8 analysts giving stock ratings to ITH in the past 3 months.
EPS
Reported
Estimate
Reported
Estimate
Surprise
Revenue
Reported
Estimate
Reported
Estimate
Surprise
This info isn't a recommendation for what you should personally do, so please don't take the data as investment advice. As with any trade, always look first, then leap. Read more in the Terms of Use.
Frequently Asked Questions
ITH EPS for the last quarter is −0.16 EUR despite the estimation of −0.18 EUR. In the next quarter EPS is expected to reach −0.13 EUR. Track more of NEKTAR THERAPEUTICS financials and stay on top of what is up with the company.
In the next quarter NEKTAR THERAPEUTICS revenue is expected to reach 35.42 M EUR. Check out NEKTAR THERAPEUTICS revenue and earnings and make informed decisions.
According to analysts, ITH price target is 3.98 EUR with a max estimate of 6.74 EUR and a min estimate of 1.25 EUR. Check if this forecast comes true in a year, meanwhile watch NEKTAR THERAPEUTICS stock price chart and keep track of the current situation with ITH news and stock market news.
We've gathered opinions of 8 analysts rating ITH stock in the past 3 months. After counting all points of view, the overall rating was calculated as buy. Note that it's not a trading advice — your own analysis is still required.